ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Sebelius: Congress Harming Nation’s Investment in Science

October 4, 2013

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

Study Explores Reasons Women Avoid Mammograms

February 25, 2011

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

April 29, 2011

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993